Actively Recruiting
Radical Surgery for Advanced Gastric- or GEJ-cancer With Oligometastatic Dissmination to the Liver
Led by Aarhus University Hospital · Updated on 2024-10-04
20
Participants Needed
1
Research Sites
208 weeks
Total Duration
On this page
Sponsors
A
Aarhus University Hospital
Lead Sponsor
R
Rigshospitalet, Denmark
Collaborating Sponsor
AI-Summary
What this Trial Is About
Offering treatment with potential to cure for participants with no such offer in today's standard treatment options, by offering metastatectomia and standard treatment with intention to cure i.e., neoadjuvant chemotherapy and gastrectomy for participants with gastric- og gastroeusofageal junction cancer. Including 20 participants from all 4 centres in Denmark able to perform the surgical procedures in question. Endpoints: 2-year overall survival.
CONDITIONS
Official Title
Radical Surgery for Advanced Gastric- or GEJ-cancer With Oligometastatic Dissmination to the Liver
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age over 18
- Confirmed primary T1-T4N0-N3M1 adenocarcinoma of the stomach or gastroesophageal junction with maximum 30% liver involvement
- Tumor that can be surgically removed based on imaging
- Fit for surgery with ASA score less than or equal to III and WHO performance status 0-1
- Eligible for systemic chemotherapy using the FLOT regimen
- Provided informed consent
You will not qualify if you...
- Cancer that cannot be surgically removed
- Tumor growing directly into nearby organs such as pancreas, colon, blood vessels, or bones
- Other cancers diagnosed or treated within 2 years before joining, except non-aggressive skin cancers
- Previous surgery that changed the normal anatomy of the upper digestive tract
- Body mass index (BMI) less than or equal to 18
- Unable to read or understand the consent form
- Other serious illnesses or acute infections
- Pregnant or breastfeeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Aarhus Univercity hospital
Aarhus, Jylland, Denmark, 8200
Actively Recruiting
Research Team
J
Julie Lykke Harbjerg, MD
CONTACT
D
Daniel Willy Kjaer, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here